Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium

The development of LBP should be approached with a strong emphasis on microbiological evaluation, clinical relevance, scientific mechanisms and safety at every stage. These measures are essential to ensure the safety, effectiveness and long-term success of the product.

Authors

Institutions

Publication Details

Journal
Gut
Published
2025-02-26
DOI
https://doi.org/10.1136/gutjnl-2024-334501
Citations
19
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
26.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium

Sung‐Liang Yu, Emad El‐Omar, Chun‐Ying Wu, Ming‐Chih Hou et al.
19 citations
Gut
Clostridium difficile and Clostridium perfringens research
26.53
article

Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium

Sung‐Liang Yu, Emad El‐Omar, Chun‐Ying Wu, Ming‐Chih Hou, Sunny H. Wong, Cheng‐Yen Kao, Yeong Yeh Lee, Jiing‐Chyuan Luo, Joseph J.�Y. Sung, Jyh‐Ming Liou, Deng‐Chyang Wu, Jun Terauchi, Hsin‐Chih Lai, Jun Qing Yu, Ching‐Hung Tseng, Jiunn‐Jong Wu, Ming-Shiang Wu
article en
19 citations

Abstract

The development of LBP should be approached with a strong emphasis on microbiological evaluation, clinical relevance, scientific mechanisms and safety at every stage. These measures are essential to ensure the safety, effectiveness and long-term success of the product.

GutVol. 74(5)
Asia University (TW), National Yang Ming Chiao Tung University (TW), Kaohsiung Medical University (TW), National Taiwan University (TW), Nanyang Technological University (SG), Chang Gung University (TW), Chinese University of Hong Kong (HK), China Medical University (TW), Kaohsiung Medical University Chung-Ho Memorial Hospital (TW), Taipei Veterans General Hospital (TW), UNSW Sydney (AU), Hospital Universiti Sains Malaysia (MY), TaiGen Biotechnology (Taiwan) (TW), Japan Biological Informatics Consortium (JP), National Taiwan University Hospital (TW), National Yang Ming Chiao Tung University (TW)
Partnerships for the goals
Openalex Percentile: Top 0%
Clostridium difficile and Clostridium perfringens research
26.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.